IPO Issue Details
Issue Price / Price Band₹50 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size3,000 Shares per Lot
Total Issue Size15,12,000 shares (aggregating up to ₹7.56 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenMon, 25 Sep 2017
Subscription CloseWed, 27 Sep 2017
Anchor AllotmentSun, 24 Sep 2017
Basis of AllotmentTue, 03 Oct 2017
Initiation of RefundsWed, 04 Oct 2017
Credit of Shares to DematWed, 04 Oct 2017
Listing DateFri, 06 Oct 2017
UPI Mandate Deadline2017-09-27
Application & Investment Details
Retail — Min (1 Lots)150000 — 3000 shares
Retail — Max (13 Lots)₹1,950,000 (13 Lots)
HNI — Min (2 Lots)300000 — 6000 shares
Net Offer to Public14,34,000 shares (aggregating up to ₹7.17 Cr)
Reserved for Market Maker78,000 shares (aggregating up to ₹0.3900 Cr)
Pre-IPO Promoter Holding42,16,000 shares
Post-IPO Promoter Holding57,28,000 shares
About Vanta Bioscience Ltd
Incorporated in 1995, Vanta Bioscience Ltd (VBL) is a preclinical contract research company which offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.In addition they also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBL also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.One of the major services of VBL is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Toxicology and safety assessment are sometimes used interchangeably and considered as synonymous.Vanta Bioscience based in Des Moines, Iowa with additional offices in Brussels, Belgium; and West Des Moines, Iowa. It has a toxicology research facility in Chennai, India.
Objects of the Issue
Vanta Bioscience Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Augmenting additional working capital requirements
6.79
2
General Corporate Purposes
0.27
Shareholding & Lock-in
Pre-IPO Promoter Holding
42,16,000 shares
Post-IPO Promoter Holding
57,28,000 shares